BELITE BIO INC - AMERICAN DEPOSITARY SHARES
80.23
22-نوفمبر-24 15:44:58
15 متأخرة بدقائق
الأسهم
-2.22
-2.69%
نطاق اليوم
78.00 - 82.07
ISIN
N/A
المصدر
NASDAQ
-
04 مايو 2023 10:09:06 بحسب Nasdaq GlobeNewswire
-
25 أبريل 2023 15:30:00 بحسب Nasdaq GlobeNewswire
-
11 أبريل 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results
31 مارس 2023 18:03:37 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on April 3, 2023 to Discuss 2022 Full Year Financial Results
31 مارس 2023 11:57:14 بحسب Nasdaq GlobeNewswire
-
18 نوفمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to discuss LBS-008 Interim Data
20 أكتوبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
01 أكتوبر 2022 18:03:33 بحسب Nasdaq GlobeNewswire
-
23 سبتمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Receives Approval of LBS-008 Phase 3 Clinical Trial in China
16 سبتمبر 2022 07:00:32 بحسب Nasdaq GlobeNewswire
-
Belite Bio Initiates Pivotal Phase 3 Clinical Trial of LBS-008 in Stargardt Disease in the U.S.
22 أغسطس 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports First Half 2022 Operational Highlights and Financial Results
10 أغسطس 2022 20:51:10 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Conference Call on August 11, 2022 to Discuss First Half 2022 Financial Results
01 أغسطس 2022 15:10:00 بحسب Nasdaq GlobeNewswire
-
19 يوليو 2022 15:05:33 بحسب Nasdaq GlobeNewswire
-
Belite Bio Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
12 مايو 2022 15:30:00 بحسب Nasdaq GlobeNewswire
-
05 مايو 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
Belite Bio Announces Closing of $36 Million Initial Public Offering
03 مايو 2022 15:30:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Receives FDA Fast Track Designation For LBS-008
03 مايو 2022 05:50:00 بحسب Nasdaq GlobeNewswire